Late and localized extramedullary relapse of a light chain kappa myeloma after syngeneic bone marrow transplantation

被引:16
作者
Trullemans, F
Schots, R
Storme, G
Van Camp, B
机构
[1] AZ VUB, Dept Med Oncol & Hematol, BMT Unit, B-1090 Brussels, Belgium
[2] AZ VUB, Dept Radiotherapy, B-1090 Brussels, Belgium
关键词
myeloma; extramedullary relapse; syngeneic BMT;
D O I
10.1038/sj.bmt.1702092
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We report the case of a 54-year-old female patient with stage IIIA kappa light chain myeloma (MM) who relapsed 7 years after syngeneic bone marrow transplantation (BMT). The relapse occurred as a voluminous soft tissue plasmacytoma in the leg, developing after local trauma. The patient was successfully treated with local radiotherapy and has remained progression-free for more than 2 years. This case represents one of the longest survivors, in complete remission, after syngeneic transplantation for MM. The presentation of recurrent disease as localized plasmacytoma with extramedullary growth is unusual in the post-transplant setting.
引用
收藏
页码:115 / 117
页数:3
相关论文
共 11 条
[1]   A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J].
Attal, M ;
Harousseau, JL ;
Stoppa, AM ;
Sotto, JJ ;
Fuzibet, JG ;
Rossi, JF ;
Casassus, P ;
Maisonneuve, H ;
Facon, T ;
Ifrah, N ;
Payen, C ;
Bataille, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :91-97
[2]  
Bensinger WI, 1996, BONE MARROW TRANSPL, V18, P527
[3]   Allogeneic stem cell transplantation for multiple myeloma [J].
Bensinger, WI ;
Buckner, CD ;
Gahrton, G .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (01) :147-&
[4]  
CELSING F, 1992, EUR J HAEMATOL, V49, P108
[5]   COMBINATION CHEMOTHERAPY VERSUS MELPHALAN AND PREDNISOLONE IN THE TREATMENT OF MULTIPLE-MYELOMA - AN OVERVIEW OF PUBLISHED TRIALS [J].
GREGORY, WM ;
RICHARDS, MA ;
MALPAS, JS .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) :334-342
[6]   HIGH-RISK MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE MELPHALAN [J].
LOKHORST, HM ;
MEUWISSEN, OJAT ;
VERDONCK, LF ;
DEKKER, AW .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :47-51
[7]   HIGH-DOSE MELPHALAN IS NOT ASSOCIATED WITH EXTRAMEDULLARY RELAPSES IN HIGH-RISK MULTIPLE-MYELOMA [J].
MOREAU, P ;
BATAILLE, R ;
MAHE, B ;
MILPIED, N ;
HAROUSSEAU, JL .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) :1832-1832
[8]   EXTRAMEDULLARY PLASMACYTOMA - CLINICAL BEHAVIOR AND RESPONSE TO TREATMENT [J].
SOESAN, M ;
PACCAGNELLA, A ;
CHIARIONSILENI, V ;
SALVAGNO, L ;
FORNASIERO, A ;
SOTTI, G ;
ZORAT, PL ;
FAVARETTO, A ;
FIORENTINO, M .
ANNALS OF ONCOLOGY, 1992, 3 (01) :51-57
[9]   SYNGENEIC MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA [J].
TOPOLSKY, D ;
CRILLEY, P ;
LEASURE, N ;
BULOVA, S ;
BRODSKY, I .
LEUKEMIA RESEARCH, 1992, 16 (04) :415-416
[10]  
VANRIET I, 1995, STEM CELLS, V13, P22